Indoleamine-2,3-dioxygenase enzyme expression and activity in polarized dendritic cells

Cytotherapy

Volumn 11, Issue 8, 2009, Pages 1084-1089

  Wolf, Benita ^a   Posnick, David ^a   Fisher, Jan L ^a   Lewis, Lionel D ^a   Ernstoff, Marc S ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

3 dioxygenase; Dendritic cell; Immunotherapy; Indoleamine 2; Interferon gamma; Lipopolysaccharide

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; PROSTAGLANDIN E2; SUNITINIB; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ARTICLE; CELL THERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOREGULATION; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 71149118571     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903271230     Document Type: Article

References (16)

1. Ranieri E, Gigante M, Storkus WJ, G esualdo L. Translational mini-review series on vaccines: dendritic cell-based vaccines in renal cancer. Clin Exp Immunol 2007; 147: 395-400.
2. Dohnal AM, Graffi S, Witt V, E ichstill C, Wagner D, Ul-Haq S, et al. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines. J Cell Mol Med 2009 Jan;13(1):125-35; Epub 2008 Mar 17.
3. Wesa A, K alinski P, K irkwood JM, Tatsumi T, S torkus WJ. Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro. J Immunother 2007 Jan;30(1): 75-82.
4. Ten BA, K arsten ML, Dieker MC, Z waginga JJ, van Ham SM. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 2007; 25: 7145-7152
5. Hwu P, D u MX, L apointe R, D o M, T aylor MW, Y oung HA. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000; 164: 3596-3599
6. Taylor MW, F eng GS. R elationship between interferongamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5: 2516-2522
7. Lee GK, Park HJ, Macleod M, Chandler P, M unn DH, Mellor AL. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 2002; 107: 452-460
8. Munn DH, S harma MD, L ee JR, J haver KG, J ohnson TS, Keskin DB, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002 13 ; 297 : 1867-1870
9. Huttner KG, Breuer SK, Paul P, Majdic O, Heitger A, Felzmann T. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer Immunol Immunother 2005; 54: 67-77.
10. Widner B, W erner ER, S chennach H, W achter H, F uchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-2426
11. Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendriticcell maturation. Blood 2005; 106: 2375-2381
12. Drause P, Singer E, Darley PI, K lebensberger J, Groettrup M, Legler DF. Prostaglandin E2 is a key factor for monocytederived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J Leukoc Biol 2007; 82: 1106-1114
13. Wobser M, Voigt H, H ouben R, E ggert AO, F reiwald M, Kaemmerer U, et al. Dendritic cell based antitumor vaccination: impact of functionaLindoleamine 2,3-dioxygenase expression. Cancer Immunol Immunother 2007; 56: 1017-1024
14. Chon SY, Hassanain HH, Gupta SL. Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma- inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem 1996; 271: 17247-17252
15. Terness P, B auer TM, R ose L, D ufter C, W atzlik A, S imon H, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002; 196: 447-457
16. Faunce DE, Terajewicz A, S tein-Streilein J. Cutting edge: in vitro -generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 1991-1995